Answer: D. All of the above

"Resistance to β-lactams can occur in three distinct ways: expression of a β-lactamase enzyme that degrades the β-lactam, alteration of the β-lactam binding site, and reduced outer membrane permeability of the agent. The first two mechanisms are used by both gram-positive and gram-negative bacteria, whereas the third is exclusive to gram-negative bacteria. When these mechanisms occur in concert, for example, overexpression of efflux and/or porin loss along with β-lactamase production, the result is high-level β-lactam resistance."

The Three Mechanisms Explained

• Gram-negative bacteria have an outer membrane that beta-lactams must cross to reach their target (penicillin-binding proteins, PBPs).
• Beta-lactams enter via water-filled channels called porins (e.g., OmpF, OmpC in E. coli).
• Loss or mutation of these porins reduces drug influx, lowering intracellular drug concentration below therapeutic levels.
• This mechanism is exclusive to gram-negative organisms because gram-positives lack an outer membrane.

• Efflux pumps actively expel beta-lactam molecules out of the bacterial cell before they can bind PBPs.
• Key systems in gram-negatives include the MexAB-OprM pump in Pseudomonas aeruginosa and AcrAB-TolC in Enterobacteriaceae.
• Overexpression of efflux pumps, especially combined with porin loss, produces clinically significant resistance.

• This is the most clinically prevalent mechanism.
• Beta-lactamases hydrolyze the beta-lactam ring, inactivating the drug before it reaches PBPs.
• Classes include narrow-spectrum penicillinases, extended-spectrum beta-lactamases (ESBLs), AmpC cephalosporinases, and carbapenemases (e.g., KPC, NDM, OXA-48).
• Beta-lactamase inhibitors (clavulanate, tazobactam, avibactam, etc.) are used to overcome this mechanism.

Why the Combination Matters

• Tietz Textbook of Laboratory Medicine, 7th Ed., p. 3278